Eagle Health Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.8M | Sell |
|
|||||
|
2025
Q2 | $15M | Sell |
|
|||||
|
2025
Q1 | $17.7M | Sell |
|
|||||
|
2024
Q4 | $17.9M | Hold |
|
|||||
|
2024
Q3 | $21M | Hold |
|
|||||
|
2024
Q2 | $18.5M | Buy |
|
|||||
|
2024
Q1 | $7.23M | Sell |
|
|||||
|
2023
Q4 | $26.2M | Hold |
|
|||||
|
2023
Q3 | $24.2M | Hold |
|
|||||
|
2023
Q2 | $26M | Hold |
|
|||||
|
2023
Q1 | $27.4M | Sell |
|
|||||
|
2022
Q4 | $37M | Sell |
|
|||||
|
2022
Q3 | $32.4M | Buy |
|
|||||
|
2022
Q2 | $21.8M | Buy |
|
|||||
|
2022
Q1 | $21.4M | Buy |
|
|||||
|
2021
Q4 | $19.3M | Buy |
|
|||||
|
2021
Q3 | $17M | Sell |
|
|||||
|
2021
Q2 | $18.3M | Hold |
|
|||||
|
2021
Q1 | $15.3M | Buy |
|
|||||
|
2020
Q4 | $11.2M | Buy |
|